Array-based comparative genomic hybridization (array-CGH) is a high throughput, high resolution technique for studying the genetics of cancer. Analysis of array-CGH data typically involves estimation of the underlying chromosome copy numbers from the log fluorescence ratios and segmenting the chromosome into regions with the same copy number at each location. We propose for the analysis of array-CGH data, a new stochastic segmentation model and an associated estimation procedure that has attractive statistical and computational properties. An important benefit of this Bayesian segmentation model is that it yields explicit formulas for posterior means, which can be used to estimate the signal directly without performing segmentation. Other quantities relating to the posterior distribution that are useful for providing confidence assessments of any given segmentation can also be estimated by using our method. We propose an approximation method whose computation time is linear in sequence length which makes our method practically applicable to the new higher density arrays. Simulation studies and applications to real array-CGH data illustrate the advantages of the proposed approach.
INTRODUCTION
Array-based comparative genomic hybridization (array-CGH) has become a useful technology in studying the genetics of cancer. For a given cell sample, array-CGH allows quantitative measurement of the average genomic DNA copy number at thousands of locations linearly ordered along the chromosomes. Typically, a test genomic DNA pool (e.g. genomic DNA from tumor cell sample) and a diploid reference genomic DNA pool are differentially labeled with dyes. These 2 dye-labeled samples are mixed and hybridized to a microarray chip, which is spotted with genomic targets that map to known locations on a global scale throughout the genome. The hybridized chip is then scanned, and the ratio of the test and reference fluorescence intensities for each genomic target is calculated. The ratio of the intensities of the dyes is a surrogate for the ratio of the abundance of the DNA sample labeled with the dyes. The review by Pinkel and Albertson (2005) summarizes recent developments in this technology and its potential applications.
The first step in the analysis of array-CGH data is the estimation of the real copy number at each probe location from the log intensity measurements. Note that by "copy number" we actually refer to a continuous quantity that is the average copy number at a given location over all the cells in the sample, which is often a heterogeneous population of cells with different copy numbers at any given genome location. In the last few years, several statistical approaches have been proposed for this problem, including hidden Markov models (HMM, Fridlyand and others, 2004) , recursive change-point detection (Circular Binary Segmentation [CBS], Olshen and others, 2004 ), a Gaussian model-based approach (Gain and Loss Analysis of DNA, Hupe and others, 2004) , hierarchical tree-style clustering (Clustering Along Chromosomes, Wang and others, 2005) , wavelet approximation (Hsu and others, 2005) , a Bayes regression approach (Wen and others, 2006) , and latent variable approaches using Gaussian mixture models (Engler and others, 2006; Broët and Richardson, 2006; Guha and others, 2006) . Most of these methods approach the problem through a segmentation perspective: they divide the genome into linearly contiguous segments with the same copy number. An important statistical problem in the implementation of such methods is the determination of the number of segments, which is sometimes referred to as the smoothness of the segmentation. Information-based model selection (Picard and others, 2005; Zhang and Siegmund, 2006) has been proposed as a guideline to this issue. The reviews by Willenbrock and Fridlyand (2005) and Lai, Johnson and others (2005) independently survey the effectiveness of existing methods on simulated and real data. Most methods produce a segmentation of the data but offer no way of assessing confidence in the segmentation. For complex aberration profiles, the different methods vary greatly on the location of break points and the estimated signal level, which suggests that a framework for inference is crucial.
In this paper, we propose for the analysis of array-CGH data a latent variable model and associated inference framework similar to that proposed by Engler and others (2006) , Broët and Richardson (2006) , and Guha and others (2006) . However, our model has key differences, which give it attractive statistical and computational properties, from these previous models. In particular, our model assumptions allow explicit computation of the posterior distributions of the latent variables, whereas previous methods rely on pseudolikelihood or Monte Carlo approximations. We view array-CGH experiments as producing, for each cell sample, an ordered sequence of (t, y t ) pairs, where t represents the location in the genome and y t represents the log ratio of the test versus reference spot intensities for the genomic target from that location. The segmentation model in Section 2 assumes that y t = θ t + σ t , in which t are independent standard normal random variables and θ t is an unknown step function whose prior distribution is given by a jump process with a baseline state and changed states. We assume that the baseline state is 0, since when there are no copy number changes the signal should be log 1 = 0. From the baseline state the process can jump to a changed state that has a Gaussian prior. From a changed state it can jump to another changed state or jump back to the baseline.
Since the copy number of a homogeneous sample of normal diploid cells should be 2 on all autosomal chromosomes, giving a signal of 0, the assumption of a zero baseline state is natural. Without making this assumption, most existing methods rely on a merging step after the segmentation to eliminate the small fluctuations around the baseline. The review by Willenbrock and Fridlyand (2005) suggests that ideally, a merging step should be incorporated into the initial segmentation so that not only are the results more interpretable but the additional information may allow higher specificity. This is accomplished for our method through the assumption of a baseline state. Whether nonbaseline states with close mean levels should be merged is questionable. Inhomogeneity and microevolution within a cell sample may cause the copy number changes at different locations in the genome to have different mixture components.
An important benefit of our Bayesian segmentation model is that we can use the posterior distributions of the number and locations of the change-points to provide confidence assessments of a segmentation. Moreover, the posterior probability of copy number change, which is a quantity that arises naturally from our model, can be readily computed for each genomic target, providing an easily interpretable value that can be used to rank or weight the genomic targets for downstream analysis. The Bayesian segmentation model contains certain hyperparameters. Their estimation is considered in Appendix C (see supplementary material available at Biostatistics online), where other implementation issues are also discussed. In Section 3, we apply our method to several real array-CGH data sets and illustrate the usefulness of confidence assessments for different scenarios. Section 4 evaluates the performance of our method on simulated data that are generated from our and other models. Some concluding remarks are given in Section 5, in which we also compare our approach with existing methods in the literature.
A STOCHASTIC CHANGE-POINT MODEL WITH KNOWN BASELINE

Model with known baseline and unknown changed states
We assume a change-point model, where the baseline state is known to be 0. When the signal leaves the baseline, it moves to a nonzero state; when the next jump occurs, the signal may move back to the baseline or jump to another nonzero state. Suppose the log fluorescence ratios y t follow the model
where θ t is a piecewise constant function of t. To describe the dynamics of θ t , we use the transition probability matrix
The matrix P specifies that, at time t, if the state θ t is in the 0 (baseline) state, then at time t + 1, θ t+1 stays in the 0 state with probability 1 − p or jumps to a nonzero state which follows N (µ, v) with probability p.
To allow the possibility of jumping from a nonzero state to a different nonzero state, we simply assume that the process can jump from the baseline state with probability p/2 to either of the 2 nonzero states that have the same prior distribution N (µ, v). If θ t = 0, then at time t + 1, it can stay in the last state with probability a, jump to another nonzero state with probability b, or jump back to the baseline state with probability c. The probability vectorπ = c/( p + c), 1 2 p/( p + c), 1 2 p/( p + c) satisfiesπ P =π , and thereforeπ corresponds to the stationary distribution associated with P. Note also that π(x)P(x, y) =π(y)P(y, x), so that the 3-state Markov chain with transition probability matrix P and initialized atπ is reversible. This implies that the Markov chain {θ t } has a stationary distribution π that assigns probability c/( p + c) to the baseline value 0 and probability p/( p + c) to a N (µ, v) random variable. Moreover, under the additional assumption that θ 0 is initialized at the stationary distribution, {θ t } is a reversible Markov chain; this property provides substantial simplification for the smoothing formulas in Section 2.3.
Filtering estimate of signal
Let K t = max{s t: θ s = · · · = θ t , θ s−1 = θ s } denote the nearest change-point at a location less than or equal to t. Let Y n = (y 1 , . . . , y n ) and Y i, j = (y i , . . . , y j ). Define
for 1 i t. Since the conditional distribution of θ t , given Y t and the event that K t = i and
4)
for j i, it follows that the posterior distribution of θ t given Y t is a mixture of normal distributions and a point mass at 0:
5)
where δ x denotes the probability distribution that assigns probability 1 to x. Let φ µ,v denote the density
Appendix A (supplementary material available at Biostatistics online) show that the conditional probabilities p t and q i,t can be determined by the recursions
3) and (2.5),
(2.7)
Smoothing estimate of signal
As indicated at the end of Section 2.1, {θ t } is a reversible Markov chain. Therefore, we can reverse time and obtain a backward filter that is analogous to (2.5):
in which the weights p s and q j,s can be obtained by backward induction using the time-reversed counterpart of (2.6):
We can use Bayes' theorem to combine the forward filter (2.5) with its backward variant (2.9) to derive the posterior distribution of θ t given Y n (1 t n), which is a mixture of normal distributions and a point mass at 0:
(2.10)
In particular, by Bayes' theorem
( 2.11) Applying a similar argument to the density function of the absolutely continuous component of the posterior distribution of θ t given Y n yields a formula that is proportional to β i jt . The details are given in Appendix A, which shows that
From (2.10), it follows that
Inference on segmentation and parameter subsequences
The α t and β i jt in (2.12) are posterior probabilities that are useful for inference. As shown in (2.13), α t = P(θ t = 0|Y n ). Moreover, the derivation of (2.12) in Appendix A shows that, for i t j,
For the problem of classifying location t as 0 (no copy number change or normal), G (copy number gain), or L (copy number loss), although the posterior probability α t = P(θ t = 0|Y t ) seems to provide an essential ingredient for constructing the Bayes classification rule, in practice the "normal" class usually includes a margin w beyond which the location is considered aberrant due to copy number gain or loss. The reason is that θ t is unobservable and small changes of θ t from 0 are of little biological interest. Furthermore, the posterior probability α t is more sensitive to hyperparameter settings than the posterior distribution of the meansθ t . Thus, we have found a decision rule based onθ t to be more robust. Specifically, location t is considered as G if θ t > w, as L if θ t < −w, and as 0 if |θ t | w. The choice of w, therefore, is often based on statistical (e.g. w is some multiple of σ ) and biological considerations.
With G, L, and 0 defined in this way, the Bayes rule R is a "soft" classifier determined by the posterior probabilities in the following:
Let [i, j] denote the segment whose beginning and ending locations are i and j, respectively. We can use P(C i j |Y n ) to provide confidence assessments of the abnormality (due to copy number change) of a segment [i, j] obtained by a segmentation procedure of the type described in the second paragraph of Section 1. Typically, these segmentation procedures allow some fuzziness in the specified endpoints i, j of the segment, in the sense that the actual endpoints may not be i and j but should be somewhere around them. To make this more precise, suppose the endpoints i and i (or j and j ) are considered "equivalent" if they differ by at most k locations, where k = min(k * , ( j − i)/2 ) and k * represents some prespecified precision. Then, we can use P (i , j ):|i−i | k,| j− j | k C i j |Y n to provide a posterior "confidence level" of an abnormal segment [i, j] identified by a segmentation procedure, whose endpoints are specified up to the above equivalence. Since k ( j − i)/2 , these events C i j are disjoint and therefore
Whereas C i j relates to the property that all locations in the segment [i, j] have the same copy number = 2 and that θ i = θ i−1 and θ j = θ j+1 , one may want to make inferences on other properties of a genomic segment that is not identified by a segmentation procedure. A fundamental entity from which these inferences on genomic regions can be derived is the posterior distribution of the parameter sequence {θ t : 1 t n} given Y n . It is shown in Appendix B (see supplementary material available at Biostatistics online) that this posterior distribution is that of an inhomogeneous Markov chain whose initial distribution is π and whose transition probabilities are given by
using the same notation as that in (2.12). Making use of the transition probabilities (2.16) of the inhomogeneous Markov chain, we can use the following recursive procedure to sample from the joint posterior distribution of the parameters θ t 1 , . . . , θ t 2 (given Y n ) in a segment [t 1 , t 2 ]. Initialize at location t = t 1 by sampling θ t from the distribution (2.10)
with probability b jt for t j n, and set θ t = 0 with probability a t . If θ t−1 = 0, set θ t = θ t−1 with probability c t , set θ t = 0 with probability a t , and sample from N (µ t, j , v t, j ) with probability b jt for t j n. The posterior distribution of (θ t 1 , . . . , θ t 2 ) given Y n , evaluated from a large number of simulated trajectories sampled from it can be used for statistical inference on the segment [t 1 , t 2 ]. Some specific applications are given in Section 3.2, in which the special case t 1 = 1 and t 2 = n covers an entire genome.
Bounded complexity mixture approximations
Although the Bayes filter (2.5) uses a recursive updating formula (2.6) for the weights q i,t (1 i t), the number of weights increases with t, resulting in rapidly increasing computational complexity and memory requirements in estimating θ t as t keeps increasing. A simple idea to lower the complexity is to keep only a fixed number k of weights at every stage t (which is tantamount to setting the other weights to be 0). Following Lai, Liu, and Xing (2005) who consider the case without a baseline state, we keep the most recent m weights q i,t (with t − m < i t) and the largest k − m of the remaining weights, where 1 m < k. Specifically, the updating formula (2.6) for the weights q i,t is modified as follows to obtain a bounded complexity mixture (BCMIX) approximation.
choosing i t to be the one farthest from t if the minimizing set in (2.17) has more than one element. Define
For the smoothing estimate E(θ t |Y n ) and its associated posterior distribution, we can construct BCMIX approximations by combining forward and backward BCMIX filters, which have index sets K t for the forward filter and K t+1 for the backward filter at stage t. The BCMIX approximation α t δ 0 + i∈K t , j∈{t}∪K t+1 β i jt N (µ i j , v i j ) to (2.10) is defined by
APPLICATIONS TO REAL DATA SETS
We now illustrate our method and examine its performance on several real array-CGH data sets. In Section 3.1, we consider the bacterial artificial chromosome (BAC) array hybridizations of the Coriel cell lines from Snijders and others (2001), which are taken from 15 primary breast tumors. Out of these 15 cell lines, we use the 9 which have known karyotype data. These cell lines have been used extensively for validation purposes in numerous methodological studies, since the true karyotypes are known. However, because the chromosomal aberration profile in this data set is relatively simple, most methods give similar segmentations and good estimates of the true signals.
In Section 3.2, we use the BAC array hybridization of the BT474 cell line, taken from Snijders and others (2003) , to illustrate some of the inferential procedures that are possible with our method. The cell line is taken from tumors with more complicated aberration profiles than those of the Coriel cell lines, as is evident from the array-CGH plots in Figure 3 and see supplementary Figure 1 available at Biostatistics online. These more challenging data sets do not reveal obvious segmentations, and thus a framework for inference becomes crucial.
Finally, in Section 3.3 we evaluate the performance of our method on Glioblastoma multiforme (GBM) cell lines from Bredel and others (2005) . These data have been used by Lai, Johnson, and others (2005) to evaluate 11 different methods, which can be directly compared to the performance of our method.
Coriel breast cancer data
The 9 cell lines that we used in our study are GM13330, GM13031, GM07081, GM05296, GM03563, GM03134, GM01750, GM01535, and GM01524. From the karyotype information, we can estimate the true signal level θ i as follows: if a probe i lies in a region where the karyotype is 2, we set θ i = 0. Otherwise, the probe lies in a changed region for which the boundaries are known, and we set θ i to be the mean of all probes in that region. Note that we need to estimate the true signal from the data even when the true copy number is known because of the nonlinear relationship between measured fluorescence ratio and copy number that may differ slightly across data sets (Pinkel and Albertson, 2005) .
To estimate the hyperparameters of our model, which will be called the stochastic change-point (denoted by SCP) model in the sequel, we note that since the Coriel cell lines have a relatively small number of aberrant segments, the probability p of jumping from the zero state to a nonzero state should be small and the probability b of jumping from a nonzero state to another nonzero state should be even substantially smaller. Therefore, we set b = 0, ruling out jumps from an infrequent nonzero state to another nonzero state and use the hybrid procedure described in the last paragraph of Appendix C (see supplementary material available at Biostatistics online), limiting the global search to 10 −4 < p < 0.005 and 10 −4 < c < 0.05. For such simple cell lines, we recommend setting the hyperparameters around reasonable values as done above, since with so few aberrant regions there may be not enough data to estimate some of the hyperparameters, such as b. However, one could potentially pool data across samples to estimate the hyperparameters via EM. Figure 1 plots the posterior means E(θ t |Y n ), 1 t n, for 4 of the 9 cell lines. Our method yields correct estimates for the other 5 cell lines, which have plots similar to those in the top panel. For this simple data set, the true copy numbers are known. As can be seen from the plots, our method perfectly distinguishes the signals from the noise for all cell lines except GM05296 and GM07081. For GM05296 there were 2 false-positive and for GM07081 there were 5 false-positive aberration calls. To give another assessment of the performance of our method, we calculated the L 1 distance n t=1 | θ t − θ t | for the estimated signal produced by a given method. The methods that we choose for comparison are the HMM-based algorithm (HMM) of Fridlyand and others (2004) and the CBS algorithm of Olshen and others (2004) . For HMM, we start with 5 states in the HMM and apply the state-merging step with a merging threshold of 0.25 as recommended in Fridlyand and others (2004) . For the CBS algorithm, we used the default parameters for the "dnacopy" software in Bioconductor. Figure 2 , which lists the L 1 distances for each cell line and method, shows that by assuming a known baseline, our model provides a better fit to these data than previous methods.
Breast cancer cell line BT474
For the cell line BT474, we use the EM algorithm in Appendix C (see supplementary material available at Biostatistics online) to estimate the hyperparameters. With initial values of ( p, a, b) at (0.05, 0.995, 0.0025) and (µ, v, σ 2 ) at (0.065, 0.087, 0.020), the EM algorithm stops after 7 iterations according to a convergence criterion, yielding p = 0.7196, a = 0.9147, c = 0.0662, µ = 0.3063, v = 0.5668, and σ 2 = 0.0152.
The top plots of Figure 3 and supplementary Figure 1 available at Biostatistics online show respectively the array-CGH profile for chromosomes 17 and 20, with the estimated mean levels and the 2.5 and 97.5% quantiles of the posterior distribution of true signals computed by our model. The qth quantile of the posterior distribution of θ t given Y n , which is a mixture of normal distributions and a point mass at 0 given by (2.10), is obtained by solving the equation
Because of the complexity of this cell line, previous methods disagree widely on the correct segmentation, as can be seen by comparing the signal estimates given by CBS, HMM, and our method on these 2 chromosomes. Because of the complexity of the BT474 profile, it is important for a statistical method to be able to assess the confidence in a particular segmentation.
A striking difference between our method and CBS and HMM is that our method can capture sawtooth patterns such as those found in the q-arm of chromosomes 17 and 20 (see Figure 3 , 50-to 70-Mb region, and supplementary Figure 1 available at Biostatistics online, 40-to 60-Mb region). The sawtooth patterns are smoothed out by CBS and HMM, primarily because these methods aim to segment the data, while our method estimates the true signal without imposing a segmentation. These sawtooth patterns are very frequently seen in highly rearranged breast tumors and are generally recognized as a real phenomena and not system noise. They have generated much biological interest because they may provide clues to the specific path that cells took to acquire them. For example, Hicks and others (2005) discuss the possible biological mechanisms that generated such patterns, which they also found by ROMA CGH.
Through our model, we provide a framework for multiple levels of inference. At the genome level, it is often of interest to rank the detected chromosomal aberrations by the confidence that it is a true aberration. This allows a prioritization of downstream studies and experiments, so that they can be targeted to genomic regions of higher statistical significance. We make use of the formulas in Section 2.4 to calculate P(C i j |Y n ), which is the posterior probability of an aberration with the left boundary i and The corresponding posterior means ( j − i + 1) −1 j t=i E(θ t |Y n ) are also shown.
the right boundary j, for all i < j, on the same chromosome arm. In Table 1 , the aberrations detected in BT474 are ranked by P(C i j |Y n ). Comparing Table 1 with Figures 3 and supplementary Figure 1available at Biostatistics online, we see that the aberrations that are visually evident in chromosomes 17 and 20 are also ranked high in the table. For example, the focal aberration on chromosome 17, which contains the well-studied ERBB2 amplicon, is at the top of the ranking with a probability of 1. Other segments that top the list, mostly amplicons on chromosomes 11, 17, and 20, are well known, as they have been identified by previous studies and in other breast cancer cell lines (e.g. Pollack and others, 1999; Pinkel and others, 1998) . In comparison, segmental duplications and deletions, such as those on chromosomes 9 and X, are ranked lower than the focal aberrations in the list. This is desirable if biologists wish to zoom in on a narrow region that has undergone strong selective pressure. Finer scale confidence assessments targeted at a specific genome region also arise naturally from our framework. We illustrate this with the data from chromosome 20 in BT474 (Supplementary Figure 1) . This region of the genome has been under scrutiny in many cancer studies, partly due to the fact that it contains several candidate oncogenes (e.g. AIB1, TFAP2C, and STK15). Supplementary Figure 1 shows several distinct aberrations in this region for BT474. However, it may be of interest to assess the relative likelihood of a sawtooth pattern consisting of at least one spike within the 40-to 50-Mb region, as compared to a flat segmentation given by HMM and CBS that assigns a uniform mean to this region. It is biologically meaningful and critical to make these distinctions because differences in such minute details of the segmentation can point to differences in the history of progression of the tumor, as well as different arrangements of the segments in the genome. The posterior confidence level (2.15) , with k * = 2, for a single segment in 40-to 50-MB region proposed by the HMM procedure is 0.000, whereas
which exceeds 0.997, 0.999, and 1, respectively, for the segments [i , j ] = A, B, C within the 40-to 50-Mb region in Supplementary Figure 1 . Thus, the probability of a spike within the 40-to 50-Mb region far outweighs the probability of a uniform mean level in that region.
The total number of changes in chromosome copy number is a useful indicator of genome instability and has been shown to be correlated with many factors such as disease stage, degrees of aneuploidy, and tumor heterogeneity (Fabarius and others, 2003; Pinkel and Albertson, 2005) . Existing segmentation algorithms are able to provide an estimate of the number of change-points through a hard segmentation. However, for a complex aberration profile such as BT474, a confidence bound for the number of changepoints can be much more informative. For the BT474 cell line, the modified BIC (Zhang and Siegmund, 2006) peaks at 30 change-points. With HMM, 103 change-points are found if the state-merging step proposed by Fridlyand and others (2004) is not taken; after the merging of states, the complete procedure from Fridlyand and others (2004) reports 69 change-points for this data series.
We use the Monte Carlo procedure described in Section 2.4 to construct confidence bounds for the total number of change-points in the genome. Define (3.18) in which the threshold δ is used to exclude negligibly small jumps that can occur in our Gaussian jump model. The posterior distribution of κ given Y n is computed by Monte Carlo, using simulated sequences generated from the fitted model by using (2.16). Supplementary Figure 2 available 
GBM data
To facilitate comparison with other methods on real array-CGH data, we also analyzed the GBM data of Bredel and others (2005) . This data set has been used in the comparative analysis of Lai, Johnson, and others (2005) , comparing the estimates of the signal for 11 methods that are different from ours. Guha and others (2006) also used these data to assess their method. Figure 4 shows the results of our method on GBM29 chromosome 7 and GBM31 chromosome 13. All analyses are done with EM hyperparameter estimation using default settings. GBM29 chromosome 7 is typical of midsize high amplitude aberrations. Our method correctly calls 3 regions of amplification. Figure 4 also shows the confidence bands. The confidence band for GBM29 chromosome 7 is relatively narrow compared to the jumps, indicating a very strong signal. On the other hand, GBM31 chromosome 13 contains a low amplitude deletion that was missed by many of the previous methods (Lai, Johnson, and others, 2005) . Our algorithm is able to call this deletion correctly, as shown by Figure 4 . However, the confidence bands are rather wide, indicating that this is a relatively difficult data set.
SIMULATIONS
We also tested our method using simulation studies, in which the true signal is known and thus various measures of accuracy can be computed. The simulation data are generated from y t = θ t + t , 1 t n, Fig. 5 . Misclassification rates for CBS, HMM, and SCP compared to the simulation data generated by the HMM of Fridlyand and others (2004) , the SCP model, and the frequentist model (CBS) of Olshen and others (2004) .
where t are i.i.d. N (0, σ 2 ) and one of the following 3 models is used to generate θ t : (a) the HMM of Fridlyand and others (2004) , in which {θ t } is a finite-state Markov chain; (b) the SCP model described in Section 2; (c) the frequentist model considered by Olshen and others (2004) , in which θ t is a fixed piecewise constant function. The parameters of the above models are determined by fitting the model to the BT474 breast cancer cell line. For the HMM, the parameters consist of the state means {θ i } K i=1 , the K × K state transition matrix, and the noise variance. The number of states K = 7 was chosen by Akaike information criterion. For the stochastic change-point model, the hyperparameters are p, a, b, c , v, and σ defined in Section 2, with values given in Section 3.2. For the frequentist model, the θ t are the estimated mean levels for BT474 using the CBS algorithm. We used n = 2056 for all 3 models, which is the same length as the complete BT474 data set without missing values. Supplementary Figure 3 available at Biostatistics online shows an example of a simulation data series generated from each of the 3 models. The series generated from the CBS model looks most similar to "real" array-CGH data because it keeps the fitted means from BT474 and only simulates the errors. The series generated from the HMM involves more randomization: it keeps the estimated state means and variances from BT474, but simulates the locations of changes as well as the errors. The series generated from the SCP model appears to be most unlike the original BT474 data series: it only keeps the hyperparameters estimated from BT474 and randomly simulates the state means, transition points, and errors. Thus, this variety of simulation models provides a fair assessment of our method.
We simulated 100 data series from each model for this study. For our method, we first run the EM algorithm with 20 iterations to estimate the hyperparameters and then compute the posterior means for each simulated sequence.
We consider the performance of our classification procedure described in the second paragraph of Section 2.4. We choose the threshold w = 2 σ for each sequence, in which σ is the estimate of σ determined by our method. For the data simulated by HMM and frequentist models, the threshold ranges from 0.35 to 0.40; for the data simulated by our model, the threshold ranges from 0.20 to 0.25. These thresholds are quite small compared to the signal sequence and are therefore fair parameters to use. Figure 5 shows the false-positive and false-negative rates (in classifying no change versus a gain or a loss) for the 3 different methods in each of the 3 simulation models. For CBS and HMM, only a hard segmentation of the data is produced, and thus we assign a probe to a changed state if the absolute value of its estimated mean is above the threshold w = 2 σ .
DISCUSSION
We have developed a SCP model for inference on array-CGH data sets. The model allows exact computation, through recursive formulas given in Section 2.2, of the parameters of the posterior distribution of the signal {θ t : 1 t n}. From the posterior distribution of the signal, given the observations, a segmentation of the data and a classification of the probes can be obtained. A Monte Carlo method for sampling from the joint posterior distribution of {θ t } is given in Section 2.4, which allows inference on almost any quantity of interest to the biologist. An approximation to the exact explicit formulas, using the BCMIX method, allows our method to be executed almost instantaneously for BAC arrays. Estimation of the hyperparameters involves an explicit EM algorithm or a hybrid method described in Appendix C. The signal estimates and inference from our method are robust to changes in the hyperparameters within a narrow range of their optimal value. In practice, the performance of our model is better when the training set used for estimation of hyperparameters is large.
In Section 3, we have used several data sets to illustrate the application of our method. In particular, we have focused on illustrating the types of inference that are possible with our method. For example, in Section 3.1 we give a method for calculating pointwise marginal confidence intervals for the estimated signal. In Section 3.2, we give a ranking of the most "interesting" aberrations in the complex data set from BT474. The aberrations that top this list are those found by most previous methods, while those that are further down the list have lent to disagreements. Instead of producing a hard segmentation, our method produces a list of aberration calls with associated posterior probabilities, giving the biologist an informed option to investigate further.
A departure of our model from most earlier models is the assumption of a baseline state, which yields a natural classification of genomic regions into "amplified," "deleted," and "normal" states. The models recently proposed in Engler and others (2006) , Guha and others (2006) , and Broët and Richardson (2006) also give such a classification rule. However, these papers do not provide explicit formulas for computing posterior probabilities and instead rely on pseudolikelihood or Markov chain Monte Carlo approaches, which may require heavy computation to obtain good approximations. We provide explicit formulas for Bayesian analysis and maximum likelihood estimation of the hyperparameters. Because of our model assumptions, if the data do not have a baseline state at 0, then our method would not perform very well. However, for array-CGH data, if the baseline state is not at 0, then normalization procedures can usually be applied to get a zero baseline state.
We chose to conduct our data analysis at the genome level, rather than at the chromosome level because the interchromosome difference in baseline signal level for BT474 and the Coriel cell lines is negligible for our model. Also, pooling data across chromosomes allows a more accurate estimate of the hyperparameters. The fact that multichromosome analysis improves sensitivity has also been shown in Engler and others (2006) . Finally, genome scale analysis allows the detection of copy number changes involving entire chromosome arms, which would be missed in chromosome-level analyses for which no actual change-points exist.
The data sets used in Section 3 are from BAC arrays, which use bacterial artificial chromosomes as genomic targets. Other platforms for array-CGH have been designed, such as cDNA arrays (Pollack and others 2002) , molecular inversion probe technology (Hardenbol and others 2003) , and oligonucleotide arrays (Komura and others 2006) . Wen and others (2006) have pointed out the need for incorporating possible changes in both the mean and variance in the analysis of cDNA array-CGH data. By making use of the ideas of Lai and others (2005) to model changes in both the error variance and the regression parameters, it should be possible to extend the methods and results of the present paper to accommodate changes in σ with θ i and to incorporate possible correlations among the observations. This is a topic for future research.
The software used in this paper was written in R and C + + and is freely available at http://wwwstat.stanford.edu/nzhang/SCP/.
